
PCI Biotech Holding ASA (0JGL.L)
0JGL.L Stock Price Chart
Explore PCI Biotech Holding ASA interactive price chart. Choose custom timeframes to analyze 0JGL.L price movements and trends.
0JGL.L Company Profile
Discover essential business fundamentals and corporate details for PCI Biotech Holding ASA (0JGL.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
18 Jun 2008
Employees
5.00
Website
https://www.pcibiotech.comCEO
Ronny Skuggedal
Description
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
0JGL.L Financial Timeline
Browse a chronological timeline of PCI Biotech Holding ASA corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Aug 2026
Earnings released on 23 May 2025
Earnings released on 27 Feb 2025
Earnings released on 28 Aug 2024
EPS came in at -kr 0.10, while revenue for the quarter reached kr 1.71M.
Earnings released on 24 May 2024
EPS came in at -kr 0.10, while revenue for the quarter reached kr 1.71M.
Earnings released on 14 Feb 2024
EPS came in at -kr 0.11, while revenue for the quarter reached kr 1.29M.
Earnings released on 31 Dec 2023
EPS came in at -kr 0.11, while revenue for the quarter reached kr 1.29M.
Earnings released on 30 Jun 2023
EPS came in at -kr 0.15, while revenue for the quarter reached kr 185.00K.
Earnings released on 31 Mar 2023
EPS came in at -kr 0.16, while revenue for the quarter reached kr 232.00K.
Earnings released on 31 Dec 2022
EPS came in at -kr 0.18, while revenue for the quarter reached kr 1.19M.
Earnings released on 30 Sept 2022
EPS came in at -kr 0.29, while revenue for the quarter reached kr 1.19M.
Earnings released on 30 Jun 2022
EPS came in at -kr 0.39, while revenue for the quarter reached kr 1.19M.
Earnings released on 31 Mar 2022
EPS came in at -kr 0.62, while revenue for the quarter reached kr 1.19M.
Dividend declared on 15 Mar 2022
A dividend of kr 0.29 per share was announced, adjusted to kr 0.29.
Earnings released on 31 Dec 2021
EPS came in at -kr 0.67, while revenue for the quarter reached kr 1.19M.
Earnings released on 30 Sept 2021
EPS came in at -kr 0.57, while revenue for the quarter reached kr 1.19M.
Earnings released on 30 Jun 2021
EPS came in at -kr 0.49, while revenue for the quarter reached kr 2.31M.
Earnings released on 31 Mar 2021
EPS came in at -kr 0.64, while revenue for the quarter reached kr 1.59M.
Earnings released on 31 Dec 2020
EPS came in at -kr 0.71, while revenue for the quarter reached kr 1.57M.
Earnings released on 30 Sept 2020
EPS came in at -kr 0.57, while revenue for the quarter reached kr 1.96M.
0JGL.L Stock Performance
Access detailed 0JGL.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.